GB1297080A - - Google Patents

Info

Publication number
GB1297080A
GB1297080A GB1297080DA GB1297080A GB 1297080 A GB1297080 A GB 1297080A GB 1297080D A GB1297080D A GB 1297080DA GB 1297080 A GB1297080 A GB 1297080A
Authority
GB
United Kingdom
Prior art keywords
carbamyl
salts
aspartate
neutral
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1297080A publication Critical patent/GB1297080A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

1297080 Salts of pyridoxine, heptaminol and diethylaminoethyltheophylline SOC GENERALE DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES 19 April 1971 [17 April 1970] 183S8/70 Headings C2C and C2V The invention comprises salts formed from pyridoxine, heptaminol and diethylamincethyltheophylline with N-carbamyl-glutamic acid and N-carbamyl-dl- and l-aspartic acid. The salts are formed by reaction between the bases and the acids in solution in water, an alcohol or dimethylsulphoxide. In examples the following salts are prepared:-pyridoxide N-carbamyldl-aspartate (acid and neutral salts), pyridoxine N-carbamyl-l-aspartate (acid and neutral salts), heptaminol N-carbamyl-dl-aspartate (neutral salt), dicthylaminoethyltheophylline N-carbamyl-dl-aspartate (neutral salt), diethylaminoethyltheophylline N - carbamyl - l - aspartate (neutral salt), pyridoxine N-carbamyl-l-glutamate (acid and neutral salts), heptaminol N- carbamyl-l-glutamate (neutral salt) and diethylaminoethylthiophylline N - carbamyl - l - glutamate (neutral salt). Pharmaceutical compositions comprise the above-mentioned salts together with suitable carriers, for the treatment of cardiac, respiratory, neurological and muscular disorders.
GB1297080D 1970-04-17 1970-04-17 Expired GB1297080A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1838870 1970-04-17

Publications (1)

Publication Number Publication Date
GB1297080A true GB1297080A (en) 1972-11-22

Family

ID=10111604

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1297080D Expired GB1297080A (en) 1970-04-17 1970-04-17

Country Status (3)

Country Link
DE (1) DE2118109A1 (en)
FR (1) FR2086138B1 (en)
GB (1) GB1297080A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5805M (en) * 1966-07-25 1968-02-19
FR5862M (en) * 1966-07-26 1968-03-11
GB1182815A (en) * 1967-06-13 1970-03-04 Prodotti Antibiotici Spa New Salts of N-Carbamyl-Glutamic Acid and of N-Carbamyl-Aspartic Acid.

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US7230009B2 (en) 1999-03-08 2007-06-12 Medicure, Inc. Pyridoxal analogues and methods of treatment
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US7148233B2 (en) 1999-08-24 2006-12-12 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7144892B2 (en) 1999-08-24 2006-12-05 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7125889B2 (en) 1999-08-24 2006-10-24 Medicure International Inc. Treating of cardiovascular and related pathologies
US7132430B2 (en) 1999-08-24 2006-11-07 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115626B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115625B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6667315B2 (en) 2000-02-29 2003-12-23 Medicure International Inc. Cardioprotective phosphonates and malonates
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6867215B2 (en) 2000-02-29 2005-03-15 Medicure International Inc. Cardioprotective phosphonates and malonates
US7105673B2 (en) 2000-02-29 2006-09-12 Medicure International Inc. Cardioprotective phosphonates and malonates
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6861439B2 (en) 2000-03-28 2005-03-01 Medicure International, Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Also Published As

Publication number Publication date
FR2086138B1 (en) 1974-09-27
FR2086138A1 (en) 1971-12-31
DE2118109A1 (en) 1971-12-02

Similar Documents

Publication Publication Date Title
CH549590A (en) PROCESS FOR PREPARATION OF PYRAZOLO (3,4B) PYRIDINE-5-CARBOXYLIC ACID DERIVATIVES.
GB1393503A (en) Aminoadamantanes and their use as medicaments for affecting the central nervous system
GB1297080A (en)
GB1317075A (en) Purine nucleoside derivatives and a process for the manufacutre thereof
ZA706557B (en) Process for the production of 9-(b-d-arabinofuranosyl)adenine,5'=phosphate and salts thereof
GB1458049A (en) Process for preparing aryl-substituted pyridones
GR60385B (en) New propargyl-2-phenylamino-imidazolines-(2),salts thereof by addition of their acids,pharmaceutical mediums containing the above and process for their preparation
ES8306994A1 (en) Diamides of substituted hydroxymalonic acids, process for their preparation and their use as pesticides.
GR61158B (en) N-tetrahydrofurfuryl-noroxymorphone,salts thereof by addition of acid,pharmaceutical mediums containing them and process for the preparation thereof
GB1343527A (en) Amino-propanol derivatives
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
BE784923A (en) PROCESS FOR THE PREPARATION OF PHOSPHONIC ACID DIHALOGENIDES
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
GB1490290A (en) Preparation of penicillanic acid derivatives
GB1353832A (en) Sulphonium compounds of alpha-hydroxy-gamma-alkyl-mercapto butyric acid
ATA163577A (en) PROCESS FOR THE PREPARATION OF NEW 3-AMINOMETHYL-2-PHENYLBICYCLO (2,2,2) OCTANES AND OCTANES AND THEIR ACID ADDITIONAL SALTS
GB1364615A (en) Preparation of n -diethylaminoethyl - 2 - methoxy- 5 - methyl sulphonylbenzamide
GB1167062A (en) Process for the preparation of Hexahydrophthalic Acid and Anhydride
GB1451389A (en) Indolobenzazepines
GB1412891A (en) Sulphamoyl-quinazolinones
FR2042290A1 (en) Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders
CH550192A (en) PROCESS FOR THE PREPARATION OF NEW THIOHYDROXIMIC ACID DERIVATIVES.
GB1424143A (en) Process for the resolution of d,1-phenyl propanolamine
GB1329493A (en) N-alkyl-pyridyl-furamides
GB1290593A (en)

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee